Author

Camille Chatelain

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Geneviève GarciniD· 1 shared Jan Tavernier· 1 shared Jean‐François FonteneauiD· 1 shared Joëlle S. NaderiD· 1 shared Lucas TrepsiD· 1 shared Manon Souchard· 1 shared Mar Naranjo‐GómeziD· 1 shared Mireia PelegríniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Geneviève GarcinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A novel tumor-targeted interferon-α/-β receptor 1 antagonist increases replication of oncolytic vesicular stomatitis virus in a mouse mesothelioma model

Thomas Teja Ogor, Yann Bordat, Manon Souchard, Joëlle S. Nader, Geneviève Garcin, Camille Chatelain, Virginie Dehame, Sophie Deshayes, Lucas Treps, Mar Naranjo‐Gómez, Nicolas Boisgerault, Jan Tavernier, Mireia Pelegrín, Jean‐François Fonteneau

This paper develops IFNAR1 antagonists that selectively block IFNAR signaling in tumor cells, enhancing VSV oncolytic activity in mesothelioma and melanoma models.

bioRxiv · Jun 3, 2026 · PreprintImmunology